Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Microbial contaminants on the eyelid surface refer to the diverse community of bacteria, fungi, and mites that colonize the lid margin and eyelashes. Common constituents include Staphylococcus epidermidis, Corynebacterium, and Propionibacterium acnes, which are typically commensal but can become pathogenic if their population increases or the host environment changes (NIH, 2018). Overgrowth of these microbes, particularly Staphylococcus aureus and Demodex mites, is a major factor in the development of blepharitis and meibomian gland dysfunction (MGD) (StatPearls, 2023). These organisms often produce lipases that break down meibum, leading to tear film instability and ocular surface inflammation. Treatment involves reducing the microbial load using mechanical lid hygiene, topical antibiotics, or antiseptics like hypochlorous acid to restore a healthy ocular surface environment (PubMed, 2021). Furthermore, managing these contaminants is essential in surgical settings to prevent the entry of bacteria into the eye, which can cause devastating infections like endophthalmitis (PubMed, 2020).
Antimicrobial agents targeting eyelid contaminants work through several pathways: antibiotics like azithromycin inhibit bacterial protein synthesis by binding to the 50S ribosomal subunit; antiseptics like hypochlorous acid induce oxidative stress and cell wall degradation; and agents like ivermectin cause paralysis in Demodex mites by activating glutamate-gated chloride channels (StatPearls, 2023; PubMed, 2021).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Microbial contaminants on eyelid surface.